iiinova — where your digital self keeps evolving

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 28/09/2026

The September 2026 issue of KICR is out! Visit this link for some very unique case reports in nephrology 👉 kicasereports.org/current @hswapnil.medsky.social @theisn.org @nephromythri.bsky.social @kidneyboy.bsky.social

023

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 21/07/2026

KICR - kidney International Case Reports. Check out the website - kicasereports.org for some thought provoking case reports! @theisn.org @hswapnil.medsky.social

031

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 07/07/2026

Some very interesting case reports in the Issue No 2 of the Kidney International Case Reports. Open Access here 👉 www.kicasereports.org/current @hswapnil.medsky.social @theisn.org @kdjhaveri.bsky.social @nephromommy-akshu.bsky.social @divyaveerssneph.bsky.social @kidneyboy.bsky.social

063

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 02/07/2026

Kidney Konversations #Podcast Video - Episode 17. On Apple Podcasts Topic: Membranous Nephropathy Subject Expert: Dr Raja Ramachandran Co-host: @nephromommy-akshu.bsky.social podcasts.apple.com/in/podcast/k...

121

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 10/06/2026

International Faculty Spotlight #ISNCON26 A pioneering physician-scientist whose work has transformed our understanding of kidney disease & preeclampsia, Dr Ananth Karumanchi will deliver the prestigious K S Chugh Oration✨ 📍 #Kochi 📅 Dec 17–20, 2026 Register now⏰ 👉 isn-india.org/isn_registra...

011

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 05/06/2026

An important milestone, collaborating with Kidney Warriors Foundation led by Mrs Vasundhara Raghavan in patient-led research. This is important for patient voices to be heard in the field of medicine and nephrology! link.springer.com/content/pdf/... @isn-india.bsky.social

030

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 28/04/2026

The first set of cases are published on the KICR website 👉 www.sciencedirect.com/journal/kidn... @hswapnil.medsky.social @theisn.org Choose the cases you wish to read after checking out the content in a nutshell in this video👇

041

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 15/03/2026

The Launch of a New Journal - Kidney International Case Reports. Here is the inaugural Editorial. #ECNeph Everyday Cases in Nephrology gets a mention! @theisn.org @hswapnil.medsky.social www.kicasereports.org/article/S311...

052

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 13/03/2026

The newest journal Kidney International Case Reports KICR launched by the international Society of Nephrology has just put out its inaugural group of articles (in press) & an editorial. Do read them at this link 👉 www.sciencedirect.com/journal/kidn... @theisn.org @christosargyrop.bsky.social

074

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 01/12/2025

Excited to join hands with @hswapnil.medsky.social & @theisn.org in this new venture, Kidney International Case Reports. KICR seeks submissions from authors worldwide - Publication fees will be waived for all authors between Dec 1, 2025, and Dec 31, 2026. www.sciencedirect.com/journal/kidn...

1187

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 31/10/2025

Just landed in Houston! Looking forward to meeting folks at #KidneyWk - the online connect is less visible these days, I hope physical presence will bolster ties. @brianrifkin.bsky.social @hswapnil.medsky.social(I know you're not attending) @christosargyrop.bsky.social @gratefull080504.bsky.social

161

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 24/10/2025

This could be a FIRST of sorts - a patient body presenting its research at a National Nephrology Conference #ISNCON25 in India. PREM - Patient Reported Experience Measures on Prescription Practices - by pt advocate Mrs Vasundhara on 19th Dec 2025 btw 2.40pm - 4.20 pm in Lecture Hall LT2. Do join us!

041

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 24/10/2025

In a CKD pt, the fear of giving iv contrast during a CT (to diagnose cancer) is more than the fear of cancer. I need radiologists/techs to understand that A. If I’ve signed the form, I know what I’m doing! B. The risk of “contrast nephrotoxicity” is negligible, perhaps non-existent. Read the lit!

3142

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 16/10/2025

Register NOW for #ISNCON25 ✅ Conference Registration isncon2025lucknow.com/registration ✅ Workshop Registration www.isncon2025.com/workshop-reg... Pre-Conference Workshop Onconephrology -18 Dec 2025 📌 Note: Delegates must register for the conference 1st & enter their Delegate ID in workshop reg form

011

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 11/09/2025

Last Month in Nephrology. This is an excellent read. lastmonthinnephrology.wordpress.com/2025/09/11/w...

020

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 11/09/2025

Low dose Rituximab (2 doses 500 mg given 15d apart) vs modified Ponticelli in PMN - pilot RCT suggests that low-dose RTX could achieve sufficient B-cell suppressn & short-term remission rates comparable to mPR with fewer adverse events @sandhyasuresh.bsky.social indianjnephrol.org/low-dose-rit...

251

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 10/09/2025

Mesangial C4d deposition is associated with adverse clinical & pathological characteristics & is an independent risk factor for progression to kidney failure in pts with IgAN. N Gopalkrishnan et al in a Madras Medical College study.

030

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 30/08/2025

Developed by the American Heart Association in 2023, the Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) equations estimate 10yr and 30yr risk for total cardiovascular disease (CVD), including atherosclerotic CVD (ASCVD) & heart failure (HF). professional.heart.org/en/guideline...

022

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 26/07/2025

I guess it would be better to be smart (and handsome) in avoiding skin whitening creams, some of them may contain mercury. This case report from Drs Sultan, @sayalibthakare.bsky.social, Tukaram Jamale et al is evidence of that! www.tandfonline.com/doi/full/10....

043

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 13/07/2025

Kidney Konversations #podcast Episode 11 - #Genetic testing in Kidney Disease - with Dr Satish Balan. Access the Podcast here 👉 open.spotify.com/episode/3xO6... An @isn-india.bsky.social initiative

041

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 12/07/2025

#ISNCON25 The 54th Annual Conference of the Indian Society of Nephrology @isn-india.bsky.social will be held in #Lucknow in December 2025. Register NOW 👉 www.isncon2025.com @kajareeg.bsky.social @thisis-drgsp2.bsky.social @sayalibthakare.bsky.social

042

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 05/07/2025

Early Bird Registration Extended till 10th July – ISNCON 2025, Lucknow (18th–21st December) #ISNCON25 Register NOW at this link 👉 isn-india.org/isn_registra...

010

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 03/07/2025

The trial demonstrated the additive benefits of dapagliflozin, including a slower ⬇️ in kidney functn & reduced kidney volume growth, without signif safety concerns. Also dapa improved other parameters such as ⬇️ body wt, lower SBP & ⬆️ hb levels @kireports.bsky.social www.kireports.org/article/S246...

042

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 28/06/2025

A New Episode of the Kidney Konversations podcast - Episode 11 - Genetic testing in kidney disease is available on Spotify at this link 👉 open.spotify.com/episode/3xO6... #genetics #nephsky @kajareeg.bsky.social @isn-india.bsky.social @sayalibthakare.bsky.social @thisis-drgsp2.bsky.social

093

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 27/06/2025

At wk 12, mean home SBP measurements were changed from baseline by −13.6 (SD, 8.6) mmHg & −14.7 (SD, 11.0) mmHg in the amiloride & spironolactone groups, with amiloride demonstrating noninferiority to spiro. Amiloride - effective alternative for Rx of resistant hypt. jamanetwork.com/journals/jam...

010

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 25/06/2025

Case Presentations in Nephrology - An Indian Society of Nephrology Initiative YouTube Recording 👉 m.youtube.com/watch?v=0yuO... Topic: Case of Anasarca Moderator: Prof Vivekanand Jha, Chandigarh @vjha.bsky.social Presented by - Dr Jugal Mehta (Mumbai)

031

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 14/06/2025

A hospital-wide policy to administer lactated Ringer’s solution rather than normal saline did not result in a significantly lower incidence of death or readmission to the hospital within 90 days after the index admission. www.nejm.org/doi/full/10....

021

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 10/06/2025

Case Presentations in Nephrology - An @isn-india.bsky.social Initiative Register at this link 👉 in.eregnow.com/ticketing/re... Date : 12th June 2025 Thursday Time : 8:30 PM IST Onwards Topic: Case of Anasarca Moderator: Prof Vivekanand Jha, Chandigarh Presented by - Dr Jugal Mehta (Mumbai)

000

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 20/05/2025

Join us for ISNCON 2025 ! (54th Annual Conference of Indian Society of Nephrology) From 18th to 21st December, 2025 at Convention Centre, SGPGIMS, Lucknow, India. Abstract Submissions are Now Open. Submit Your Abstracts Here 👉 isn-india.org/isn_registra... @isn-india.bsky.social @theisn.org

021

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 16/05/2025

ISN India @isn-india.bsky.social 🇮🇳 Case Presentation Nephrology 📍17 May 25 Sat 📍8 PM 📍Case - Kidney Transplant 📍Moderator Dr N Gopalakrishnan @srigola751 📍Presented by Dr Archana V Plz register using link in.eregnow.com/ticketing/re...

001

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 16/05/2025

MN Hybrid therapy 👉 oral pred (starting at 60mg, tapering to 5mg by month six), oral cyclophosphamide (150mg for 1 wk foll by 100mg until mth 2)& rituximab (1g was given day 0, followed by a 2nd dose btw days 15-45, & a 3rd dose btw days 90-180) @vjha.bsky.social indianjnephrol.org/rituximab-cy...

020

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 08/05/2025

Happening today 8th May 2025 at 7.30 pm IST. Register here 👉 tinyurl.com/sueuuth6

010

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 03/05/2025

Resolution of steatohepatitis without worsening of fibrosis occurred in 62.9% in the semaglutide group & in 34.3% in the placebo group. Reduction in liver fibrosis without worsening of steatohepatitis was reported in 36.8% in the semaglutide group & in 22.4% in the placebo group tinyurl.com/338u24b2

042

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 02/05/2025

🔥 BKV Infection in Kidney Transplant Recipients- A major threat to graft survival! #nephsky 🎤 Don’t miss this exclusive webinar by @isn-india.bsky.social & @ttsorg.bsky.social featuring international experts🌍 🗓 8th May 2025 ⏰ 7:30 PM IST 🔗 Register now: tinyurl.com/sueuuth6

010

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 28/04/2025

For the folks/alumni from Mysore Medical College, I placed an order with the India Govt Mint for the commemorative coin of the centenary celebration of MMC&RI and that was delivered today! #Mysore

010

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 27/04/2025

Lorundrostat - an aldosterone synthase inhibitor. Lorundrostat was associated with greater reductions in 24-hr average BP than placebo in pts with uncontrolled & treatment-resistant hypertension. K level >6.0 occurred in 5 pts (5%) in the stable-dose group. www.nejm.org/doi/full/10.... @nejm.org

0105

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 25/04/2025

Statistics refresher at the Nephrology Association of Karnataka meeting yesterday. What is the data type and what tests hold good...

000

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 21/04/2025

*ISN Case Presentation Nephrology* @isn-india.bsky.social 23 Apr 2025 Wednesday 8 PM IST Onwards Interesting Case of Renal Failure Moderator: Prof SK Agarwal, New Delhi Presented by - Dr Jwala KA (AIIMS Nagpur) in.eregnow.com/ticketing/re... @jasminenephro.bsky.social @shahsonride.bsky.social

031

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 16/04/2025

Arvind Canchi Bangalore based Nephrologist at the #Nephjc. Have been a metformin supporter for a long time now! And keeping a score!

131

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 09/04/2025

In patients with giant-cell arteritis, upadacitinib at a dose of 15 mg — but not 7.5 mg — with a 26-week glucocorticoid taper showed efficacy superior to that of placebo with a 52-week glucocorticoid taper. www.nejm.org/doi/full/10....

040

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 04/04/2025

India thrives on incremental dialysis, so do a lot of developing countries. My choice here was right, but the BRP alas, is North of the North-South divide 🤷 and also a tad US centric 🤦‍♂️ #nephmadness

143

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 04/04/2025

70% Ethanol Lock for Mgmt of CRBSI in Tunneled Central Venous Catheters - A Study from Madurai. #nephsky "A syringe was used to dilute 3.5 mL 100% medical grade ethanol with 1.5 mL sterile distilled water to make 5 mL 70% EL solution" indianjnephrol.org/70-ethanol-l... @isn-india.bsky.social

010

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 03/04/2025

Seven out of eight correct picks for #nephmadness is an excellent start. Given the number of current conflicts happening across the world, the BRP did not get that one right ‼️

122

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 03/04/2025

Yes it is. And we do have a press release news item that shows the manufacturers..

001

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 03/04/2025

Branded Cilnidipine 10mg costs Rs 15 to 20 per tab. Branded olmesartan 40mg /CTD combo costs Rs 20 to 25 per tablet. At Janaushadhi you get these tablets at Rs 1.6 & Rs 3 respectively per tablet. Huge savings. I trust that strength & efficacy is maintained. janaushadhi.gov.in/productportf...

210

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 30/03/2025

Oral Semaglutide is the only form of GLP1RA available in India right now. Hopes that the SOUL trial results for MAKE events will follow that of the FLOW trial are dashed 😢 Tirzepatide in the injectable form has just been launched in India. And that's quite costly.

031

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 30/03/2025

Lower rates of successful pregnancy outcomes in pts with LN (35.9% vs. 63.5%), higher spontaneous abortion rates (64.1% vs. 32.9%). Increased occurrence of gestational hypertension (23% vs. 9.6%) & preeclampsia (7.6% vs. 0%) was observed in the LN group journals.lww.com/ijkd/fulltex...

052

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 29/03/2025

Tirunelveli Medical College Study-"We generated murine monoclonal/rabbit polyclonal antibodies against venom of Russell viper, saw-scaled viper & Indian cobra & developed an ELISA to distinguish the snake by analyzing the exudates from the snakebite wound 👉 academic.oup.com/labmed/advan...

010

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 28/03/2025

Learning about this Chromogranin Nephropathy for the first time. #ECNeph you beauty! So much to learn! Thank you @drsumanbehera.bsky.social and @myadla.bsky.social

2144